Merck & Co's recently approved Victrelis treatment for hepatitis C considerably...
The Food and Drug Administration's long-awaited guidelines for the sale of lower-cost...
Health regulators said ulcer drugs such as AstraZeneca Plc's blockbuster Nexium...
Cumberland Pharmaceuticals Inc. today announced that it has received a Notice...
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories,...
HUDDINGE, Sweden, February 8, 2012 /PRNewswire/ --
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the Company has...
Cadence Pharmaceuticals, Inc. , a biopharmaceutical company focused on in-licensing,...
Mylan Inc. today announced that it has successfully completed the acquisition...
Valeant Pharmaceuticals International, Inc. today announced that it has completed...
Stay updated on the latest technologies and news with Biocompare's newsletters (See samples here)